BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 26713367)

  • 1. Epigenetic down-regulated DDX10 promotes cell proliferation through Akt/NF-κB pathway in ovarian cancer.
    Gai M; Bo Q; Qi L
    Biochem Biophys Res Commun; 2016 Jan; 469(4):1000-5. PubMed ID: 26713367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DDX10 promotes human lung carcinoma proliferation by U3 small nucleolar ribonucleoprotein IMP4.
    Liu C; Tang J; Duan X; Du Y; Wang X; Cui Y
    Thorac Cancer; 2021 Jun; 12(12):1873-1880. PubMed ID: 33973712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PDCD6 additively cooperates with anti-cancer drugs through activation of NF-κB pathways.
    Park SH; Lee JH; Lee GB; Byun HJ; Kim BR; Park CY; Kim HB; Rho SB
    Cell Signal; 2012 Mar; 24(3):726-33. PubMed ID: 22142513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (E)-2,4-Bis(p-hydroxyphenyl)-2-butenal enhanced TRAIL-induced apoptosis in ovarian cancer cells through downregulation of NF-κB/STAT3 pathway.
    Cho SH; Park MH; Lee HP; Back MK; Sung HC; Chang HW; Kim JH; Jeong HS; Han SB; Hong JT
    Arch Pharm Res; 2014 May; 37(5):652-61. PubMed ID: 24390815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte growth factor (HGF) upregulates heparanase expression via the PI3K/Akt/NF-κB signaling pathway for gastric cancer metastasis.
    Hao NB; Tang B; Wang GZ; Xie R; Hu CJ; Wang SM; Wu YY; Liu E; Xie X; Yang SM
    Cancer Lett; 2015 May; 361(1):57-66. PubMed ID: 25727320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DDX10 overexpression predicts worse prognosis in osteosarcoma and its deletion prohibits cell activities modulated by MAPK pathway.
    Shi JH; Hao YJ
    Biochem Biophys Res Commun; 2019 Mar; 510(4):525-529. PubMed ID: 30738579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer.
    He D; Wang J; Zhang C; Shan B; Deng X; Li B; Zhou Y; Chen W; Hong J; Gao Y; Chen Z; Duan C
    Mol Cancer; 2015 Apr; 14():73. PubMed ID: 25889562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of interleukin-1β mediated nuclear factor κB signalling pathways to down-regulate prostate-specific antigen and cell proliferation in LNCaP prostate cancer cells.
    Bouraoui Y; Ben Rais N; Culig Z; Oueslati R
    Cell Biol Int; 2012 May; 36(5):449-54. PubMed ID: 22103356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of the nuclear factor-kappaB by lidamycin in association with inducing apoptosis in human pancreatic cancer cells and inhibiting xenograft growth.
    Chen J; Ouyang ZG; Zhang SH; Zhen YS
    Oncol Rep; 2007 Jun; 17(6):1445-51. PubMed ID: 17487403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-661 contributed to cell proliferation of human ovarian cancer cells by repressing INPP5J expression.
    Zhu T; Yuan J; Wang Y; Gong C; Xie Y; Li H
    Biomed Pharmacother; 2015 Oct; 75():123-8. PubMed ID: 26282217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic function of BMP-2 in gastric cancer cells: the role of PI3K/AKT, MAPK, the NF-κB pathway, and MMP-9 expression.
    Kang MH; Oh SC; Lee HJ; Kang HN; Kim JL; Kim JS; Yoo YA
    Exp Cell Res; 2011 Jul; 317(12):1746-62. PubMed ID: 21570392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Akt is upstream and MAPKs are downstream of NF-κB in paclitaxel-induced survival signaling events, which are down-regulated by curcumin contributing to their synergism.
    Bava SV; Sreekanth CN; Thulasidasan AK; Anto NP; Cheriyan VT; Puliyappadamba VT; Menon SG; Ravichandran SD; Anto RJ
    Int J Biochem Cell Biol; 2011 Mar; 43(3):331-41. PubMed ID: 20883815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of COX-2 protein expression by Akt in endometrial cancer cells is mediated through NF-kappaB/IkappaB pathway.
    St-Germain ME; Gagnon V; Parent S; Asselin E
    Mol Cancer; 2004 Mar; 3():7. PubMed ID: 15016316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1.
    Guo LM; Pu Y; Han Z; Liu T; Li YX; Liu M; Li X; Tang H
    FEBS J; 2009 Oct; 276(19):5537-46. PubMed ID: 19702828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-8 upregulates integrin β3 expression and promotes estrogen receptor-negative breast cancer cell invasion by activating the PI3K/Akt/NF-κB pathway.
    Shao N; Lu Z; Zhang Y; Wang M; Li W; Hu Z; Wang S; Lin Y
    Cancer Lett; 2015 Aug; 364(2):165-72. PubMed ID: 25979232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
    Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
    Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnolol down-regulates HER2 gene expression, leading to inhibition of HER2-mediated metastatic potential in ovarian cancer cells.
    Chuang TC; Hsu SC; Cheng YT; Shao WS; Wu K; Fang GS; Ou CC; Wang V
    Cancer Lett; 2011 Dec; 311(1):11-9. PubMed ID: 21757288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIM52 plays an oncogenic role in ovarian cancer associated with NF-kB pathway.
    Yang W; Liu L; Li C; Luo N; Chen R; Li L; Yu F; Cheng Z
    Cell Death Dis; 2018 Sep; 9(9):908. PubMed ID: 30185771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of PI3K/Akt/IKK-alpha/NF-kappaB signaling pathway is required for the apoptosis-evasion in human salivary adenoid cystic carcinoma: its inhibition by quercetin.
    Sun ZJ; Chen G; Hu X; Zhang W; Liu Y; Zhu LX; Zhou Q; Zhao YF
    Apoptosis; 2010 Jul; 15(7):850-63. PubMed ID: 20386985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic Regulation of KPC1 Ubiquitin Ligase Affects the NF-κB Pathway in Melanoma.
    Iida Y; Ciechanover A; Marzese DM; Hata K; Bustos M; Ono S; Wang J; Salomon MP; Tran K; Lam S; Hsu S; Nelson N; Kravtsova-Ivantsiv Y; Mills GB; Davies MA; Hoon DSB
    Clin Cancer Res; 2017 Aug; 23(16):4831-4842. PubMed ID: 28389511
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.